CHICAGO, March 22, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Viacom, Inc. (Nasdaq: VIAB), Adobe Systems Inc. (Nasdaq: ADBE), News Corp (Nasdaq: NWSA), Time Warner Inc. (NYSE: TWX) and Catalyst Health Solutions Inc. (Nasdaq: CHSI).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Wednesday's Analyst Blog:
Viacom to Boost Advertising Sales
In a bid to revamp the advertising revenue, Viacom, Inc.'s (Nasdaq: VIAB) introduced Surround Sound that promotes target advertising and eventually favors its advertisers. To carry out this process the company has implemented Adobe Systems Inc.'s (Nasdaq: ADBE) AudienceManager, a popular product that offers data management solutions to its client.
It is believed that most advertisements do not reach the target audiences. Moreover, with the availability of so many digital platforms, it becomes rather impossible to track the taste and preferences of the target audiences.
Furthermore, the recent slump in the global economy has also forced many advertisers to reduce their advertisement budgets. According to a data released by eMarketer, it is believed that about one-third of the marketers in U.S. will focus on target advertising.
Thus, introduction of Surround Sound by Viacom will enable these advertisers to gain profound knowledge about their target customers. Moreover, Adobe's AudienceManager, with the help of cookies and pixel tags, will play a leading role to collect information on customer taste and preferences.
Viacom, a large media content company, offers most of its entertainment brands through television, motion picture, Internet, mobile and video game platforms across the globe. Advertising forms an integral part of such media related companies.
In 2011, Viacom's advertisement business generated 30% of the total revenue. However, in the last quarter of fiscal 2011, the company reported decline in advertising revenue, which we believe has triggered the company to introduce such methods to gain the confidence of the advertisers.
We maintain our long-term Neutral recommendation for Viacom. Currently, it has a Zacks #3 Rank, implying a short-term Hold rating on the stock.
Based in New York, Viacom Inc. is a leading entertainment content company that operates primarily in the U.S. and Europe.
Catalyst Health Signs PBM Deal
On Monday, Catalyst Health Solutions Inc. (Nasdaq: CHSI) announced a long-term agreement with Regence Rx Inc. to exclusively provide pharmacy benefit management ("PBM") service to the latter's clients through its PBM unit - Catalyst Rx. Catalyst Health will also take over Regence's PBM staff, technology and internal client service assets. Moreover, the two companies will jointly create a pharmacy center of excellence in Northwestern U.S.
The deal will be effective from May 1, 2012 to December 31, 2017 and carries an option for an extension till December 2021. The PBM services covered by the agreement include claim settlement, mail and specialty drug management, rebate contracting, member services, network administration, data reporting, analytics, client service and sales support services. However, Regence will carry on offering clinical and contracting services to its clientele.
Both Catalyst Health and Regence will be mutually benefited by the agreement. Regence will be able to enhance its customer service on the back of Catalyst Health's efficiency in the PBM business, its large operating scale, well-established provider network and product development capabilities. On the flip side, the PBM business of Catalyst Health will get a boost as Regence Health Plans cover over 1.2 million policyholders.
Cambia Health Solutions Inc.'s subsidiary – Regence's forte lies in providing affordable PBM services. Apart from PBM, the company also offers related clinical and contracting support services to the members of other Medicaid and Blue Cross and Blue Shield plans.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.